DDAH2 and neoplasm: reported the involvement of dimethylarginine dimethylaminohydrolase (DDAH) in cerebral tumor growth and development of tumor vasculature [16]; this enzyme metabolizes the endogenous NOS inhibitor asymmetric dimethylarginine (ADMA).